EUTM file information

018913811

NAVIGNOSTICS

August 14, 2023

Trademark Summary

The trademark NAVIGNOSTICS was filed by Andrea Jacobs, a national of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on October 2, 2023, and received one opposition filed on October 12, 2023 by Navigo Proteins GmbH on Likelihood of confusion. the opponent was represented by isarpatent - Patent- und Rechtsanwälte Barth · Charles · Hassa · Peckmann & Partner mbB and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 12, 2023

It was designated 'Basic Application' for International Application 1789760 at the World Intellectual Property Organization (WIPO).

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Reactants for medical diagnosis
    2. Preparations for medical diagnosis
    3. Diagnostic reagents for medical or veterinary use in in vitro diagnosis
    4. Reactants for medical diagnosis, particularly for usage with spatial single-cell proteomics Reagents for diagnostic tests for medical use
    5. Diagnostic test reagents for veterinary use
    6. Diagnostic preparations for medical use
    7. Diagnostic radiopharmaceutical preparations
    8. Diagnostic substances for medical use
    9. Pharmaceutical products,medical and veterinary preparations
    10. Pharmaceuticals for the treatment of cancer
    11. Pharmaceutical preparations and compositions for the treatment and prevention of cancer
    12. Pharmaceutical preparations
    13. Pharmaceutical preparations for the diagnosis of diseases
    14. Pharmaceutical preparations for diagnosis
    15. Pharmaceutical preparations for diagnostic purposes
    16. Pharmaceutical preparations for individual medical diagnosis Pharmaceutical preparations for medical test kits
    17. Pharmaceutical preparations for medical test kits for use in oncology
    18. Pharmaceutical preparations for medical test kits for cancer diagnosis
    19. Pharmaceutical preparations for medical test kits for individual medical diagnosis
    20. Diagnostic test kits Diagnostic test kits for use in oncology
    21. Diagnostic test kits for cancer diagnosis
    22. Diagnostic test kits for individual medical diagnosis.
  • The mark was filed in class 10 with following description of goods:
    1. Apparatus for tumour diagnosis
    2. Medical apparatus for machine learning-based spectrum analysis of human blood plasma
    3. Scanners for medical diagnosis Apparatus for clinical diagnosis Spectrum analyzers for use in medical diagnosis Trace material analyzers for medical use in diagnosis Apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins Medical test kits
    4. Diagnostic, examination, and monitoring equipment
    5. Medical tests kits for the use in oncology
    6. Medical test kits for cancer diagnosis
    7. Medical test kits for individual diagnosis.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific research for medical purposes in the area of cancerous diseases
    2. Scientific research in the field of Proteomics
    3. Oncological research
    4. Research in the field of oncological diagnostics
    5. Medical data analysis for cancer diagnostics
    6. Development of personalized diagnostics products for cancer treatment
    7. Software-as-a-Service [SaaS] for use in cancer diagnosis
    8. Platform-as-a-Service [PaaS] for use in cancer diagnosis
    9. Software-as-a-Service [SaaS] for use in oncology
    10. Platform-as-a-Service [PaaS] for use in oncology
    11. Software-as-a-Service [SaaS] for medical and scientific research in the field of cancer treatment and diagnosis
    12. Platform-as-a-Service [PaaS] for medical and scientific research in the field of cancer treatment and diagnosis
    13. Software-as-a-Service [SaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis
    14. Platform-as-a-Service [PaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis
    15. Downloadable and recorded computer programs using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis
    16. Software for the analysis of medical data, particularly for cancer research, treatment and diagnosis
    17. Software-as-a-Service [SaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis Platform-as-a-Service [PaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis Software as-a-Service [SaaS] for the digital representation of tumours and tumour features
    18. Platform-as-a-Service [PaaS] for the digital representation of tumours and tumour features
    19. Software as-a-Service [SaaS] for high-resolution digital image representation of the molecular composition of cellular anomaliesPlatform-as-a-Service [PaaS] for high-resolution digital image representation of the molecular composition of cellular anomalies Software as-a-Service [SaaS] for high-resolution digital image representation of digital tumors Platform-as-a-Service [PaaS] for high-resolution digital image representation of digital tumors.
  • The mark was filed in class 44 with Cancer diagnosis research.